Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Sales | 2,205 | 462 | 1,540 | 395 | 700 |
| Cost of Goods | 1,531 | 483 | 462 | 403 | 536 |
| Gross Profit | -135 | -22 | 1,078 | -8 | 164 |
| Operating Expenses | 2,594 | 1,635 | 1,843 | 1,554 | 1,850 |
| Operating Income | -1,389 | -1,173 | -303 | -1,159 | -1,151 |
| Interest Expense | 74 | 77 | 78 | 77 | 69 |
| Other Income | 149 | 150 | -127 | 104 | 598 |
| Pre-tax Income | -1,314 | -1,100 | -509 | -1,131 | -622 |
| Income Tax | 192 | 60 | 0 | 5 | 8 |
| Net Income Continuous | -1,506 | -1,160 | -509 | -1,137 | -629 |
| Net Income | $-1,506 | $-1,160 | $-509 | $-1,137 | $-629 |
| EPS Basic Total Ops | -12.04 | N/A | -4.19 | N/A | -5.19 |
| EPS Basic Continuous Ops | -12.04 | N/A | -4.19 | N/A | -5.19 |
| EPS Diluted Total Ops | -11.52 | N/A | -4.19 | N/A | -5.19 |
| EPS Diluted Continuous Ops | -11.52 | N/A | -4.19 | N/A | -5.19 |
| EBITDA(a) | $-1,389 | $-1,173 | $-303 | $-1,159 | $-1,151 |